Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
GlaxoSmithKline
Eli Lilly and Company
Ascendis Pharma A/S
University of Washington
Incyte Corporation
University Health Network, Toronto
ARCAGY/ GINECO GROUP
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Sensei Biotherapeutics, Inc.
Carisma Therapeutics Inc
NextCure, Inc.
Salubris Biotherapeutics Inc
Adaptimmune